US6828431B1
(en)
*
|
1999-04-09 |
2004-12-07 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
US7241876B2
(en)
|
1996-01-11 |
2007-07-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
US6630305B1
(en)
|
1999-11-12 |
2003-10-07 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7033827B2
(en)
|
1997-02-25 |
2006-04-25 |
Corixa Corporation |
Prostate-specific polynucleotide compositions
|
US6329505B1
(en)
|
1997-02-25 |
2001-12-11 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
US6657056B2
(en)
|
1997-02-25 |
2003-12-02 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US7517952B1
(en)
|
1997-02-25 |
2009-04-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US20030185830A1
(en)
*
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6759515B1
(en)
|
1997-02-25 |
2004-07-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US7202342B1
(en)
|
1999-11-12 |
2007-04-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6465611B1
(en)
|
1997-02-25 |
2002-10-15 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6800746B2
(en)
|
1997-02-25 |
2004-10-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6894146B1
(en)
|
1997-02-25 |
2005-05-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6818751B1
(en)
|
1997-08-01 |
2004-11-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6620922B1
(en)
|
1997-02-25 |
2003-09-16 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6943236B2
(en)
|
1997-02-25 |
2005-09-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
ATE426018T1
(de)
|
1997-04-10 |
2009-04-15 |
Stichting Katholieke Univ |
Pca3, pca3-gene und verfahren zu ihrer verwendung
|
US6365369B1
(en)
|
1998-04-01 |
2002-04-02 |
Human Genome Sciences, Inc. |
Prostate specific secreted protein
|
US6861215B1
(en)
|
1998-05-21 |
2005-03-01 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging prostate cancer
|
US20060052321A1
(en)
|
2002-04-05 |
2006-03-09 |
Raitano Arthur B |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
PT1086223E
(pt)
|
1998-06-01 |
2009-11-03 |
Agensys Inc |
Novos antigénios transmembranares em serpentina expressos em cancros humanos e suas utilizações
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US7037667B1
(en)
|
1998-06-01 |
2006-05-02 |
Agensys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
US20040141975A1
(en)
|
1998-06-01 |
2004-07-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
WO2000020584A2
(en)
*
|
1998-10-02 |
2000-04-13 |
Urogenesys, Inc. |
Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
US6528054B1
(en)
*
|
1998-12-28 |
2003-03-04 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
EP1169444A2
(en)
*
|
1999-04-09 |
2002-01-09 |
Corixa Corporation |
Compositions and methods for the treatment and diagnosis of breast cancer
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
AU4484400A
(en)
*
|
1999-04-23 |
2000-11-10 |
University Of Washington |
Prostate-specific polynucleotides, polypeptides and their methods of use
|
AU5416700A
(en)
*
|
1999-05-20 |
2000-12-12 |
Fahri Saatcioglu |
Differentially expressed genes in prostate cancer
|
JP2003504080A
(ja)
*
|
1999-07-13 |
2003-02-04 |
スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム |
ワクチン
|
US7368545B1
(en)
|
1999-09-29 |
2008-05-06 |
Diagnocure Inc. |
PCA3 messenger RNA species in benign and malignant prostate tissues
|
AU7917200A
(en)
*
|
1999-09-30 |
2001-04-30 |
Institut Pasteur |
Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences
|
WO2001025272A2
(en)
*
|
1999-10-04 |
2001-04-12 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
US7208280B2
(en)
|
1999-10-05 |
2007-04-24 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
|
ES2371212T3
(es)
*
|
1999-10-05 |
2011-12-28 |
Agensys, Inc. |
Receptor acoplado a proteína g regulado positivamente en el cáncer de próstata y usos del mismo.
|
US6790631B1
(en)
|
1999-10-05 |
2004-09-14 |
Agensys, Inc. |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
AU7753700A
(en)
*
|
1999-10-07 |
2001-05-10 |
Schering Aktiengesellschaft |
Dna encoding prost 07 polypeptide
|
AU1656501A
(en)
*
|
1999-11-12 |
2001-06-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US20020048777A1
(en)
|
1999-12-06 |
2002-04-25 |
Shujath Ali |
Method of diagnosing monitoring, staging, imaging and treating prostate cancer
|
HUP0203968A3
(en)
*
|
2000-01-14 |
2004-09-28 |
Corixa Corp Seattle |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
WO2001059110A2
(en)
*
|
2000-02-08 |
2001-08-16 |
Agensys, Inc. |
34p3d7: a tissue specific protein highly expressed in prostate cancer
|
WO2001060860A2
(en)
*
|
2000-02-17 |
2001-08-23 |
Millennium Predictive Medicine, Inc. |
Genes differentially expressed in human prostate cancer and their use
|
AU4592601A
(en)
*
|
2000-03-21 |
2001-10-03 |
Millennium Predictive Medicine |
Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
|
US7611892B2
(en)
|
2000-03-24 |
2009-11-03 |
President And Fellows Of Harvard College |
Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
|
AU2001249549A1
(en)
*
|
2000-03-27 |
2001-10-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
GB0015736D0
(en)
*
|
2000-06-27 |
2000-08-16 |
Smithkline Beecham Biolog |
Vaccine
|
GB0015722D0
(en)
*
|
2000-06-27 |
2000-08-16 |
Smithkline Beecham Sa |
Vaccine
|
PL211151B1
(pl)
|
2000-10-18 |
2012-04-30 |
Glaxosmithkline Biolog Sa |
Kompozycja immunogenna oraz zastosowanie połączenia saponiny, oligonukleotydu immunostymulującego i lipopolisacharydu
|
US7048931B1
(en)
|
2000-11-09 |
2006-05-23 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
BR0115715A
(pt)
|
2000-11-28 |
2004-02-03 |
Wyeth Corp |
Análise de expressão de ácidos nucleìcos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
|
HUP0303905A3
(en)
|
2000-11-28 |
2005-11-28 |
Wyeth Corp |
Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
US7736654B2
(en)
|
2001-04-10 |
2010-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
JP2005504513A
(ja)
*
|
2001-05-09 |
2005-02-17 |
コリクサ コーポレイション |
前立腺癌の治療及び診断のための組成物及び方法
|
US6897024B2
(en)
|
2001-05-31 |
2005-05-24 |
Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen |
Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
|
ES2532757T3
(es)
|
2001-09-06 |
2015-03-31 |
Agensys, Inc. |
Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
EP1578980A4
(en)
*
|
2002-04-01 |
2013-01-02 |
Agensys Inc |
NUCLEIC ACID AND CORRESPONDING PROTEIN 213P1F11 FOR USE IN THE TREATMENT AND DETECTION OF CANCER
|
WO2003103706A2
(en)
*
|
2002-06-11 |
2003-12-18 |
Glaxosmithkline Biologicals S.A. |
Immunogenic compositions
|
JP2006512047A
(ja)
*
|
2002-06-11 |
2006-04-13 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物
|
AU2003243151A1
(en)
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
ES2427853T3
(es)
|
2003-02-07 |
2013-11-04 |
Diagnocure Inc. |
Procedimiento para detectar cáncer de próstata en una muestra
|
DK1648931T3
(da)
|
2003-07-21 |
2011-03-07 |
Transgene Sa |
Multifunktionelle cytokiner
|
AU2004319915B9
(en)
|
2004-04-22 |
2011-12-22 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
CA2491067A1
(en)
|
2004-12-24 |
2006-06-24 |
Stichting Katholieke Universiteit |
Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
|
CA2814598A1
(en)
|
2005-09-12 |
2007-03-22 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
US9957569B2
(en)
|
2005-09-12 |
2018-05-01 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
JP5470848B2
(ja)
|
2006-08-04 |
2014-04-16 |
味の素株式会社 |
肺癌の評価方法、肺癌評価装置、肺癌評価方法、肺癌評価システム、肺癌評価プログラム、記録媒体、および、情報通信端末装置
|
PT2468300T
(pt)
|
2006-09-26 |
2018-01-30 |
Infectious Disease Res Inst |
Composição para vacina contendo adjuvante sintético
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
ES2636089T3
(es)
|
2006-10-27 |
2017-10-05 |
Genentech, Inc. |
Anticuerpos e inmunoconjugados y usos para los mismos
|
EP2103940A4
(en)
|
2006-12-21 |
2013-04-24 |
Ajinomoto Kk |
METHOD, APPARATUS, METHOD, SYSTEM AND SOFTWARE FOR ASSESSING BREAST CANCER, AND RECORDING MEDIUM
|
WO2008075663A1
(ja)
|
2006-12-21 |
2008-06-26 |
Ajinomoto Co., Inc. |
大腸癌の評価方法、ならびに大腸癌評価装置、大腸癌評価方法、大腸癌評価システム、大腸癌評価プログラムおよび記録媒体
|
US9303291B2
(en)
|
2007-07-06 |
2016-04-05 |
The Regents Of The University Of Michigan |
MIPOL1-ETV1 gene rearrangements
|
US8106037B2
(en)
|
2007-08-03 |
2012-01-31 |
The Brigham And Women's Hospital, Inc. |
Identification and treatment of estrogen responsive prostate tumors
|
KR100976218B1
(ko)
|
2008-05-26 |
2010-08-17 |
한국표준과학연구원 |
비행시간이차이온질량분광법을 이용한 질병의 진단 방법,질병 지표의 스크린 방법, 및 질병 지표
|
CN102066946B
(zh)
|
2008-06-20 |
2016-08-31 |
味之素株式会社 |
前列腺疾病的评价方法
|
MX2011001445A
(es)
|
2008-08-05 |
2011-04-05 |
Toray Industries |
Metodo para detectar cancer.
|
BRPI0911926A2
(pt)
|
2008-08-05 |
2020-08-18 |
Toray Industries, Inc |
composições farmacêuticas, anticorpos e usos de um anticorpo ou um fragmento do mesmo.
|
DK2324842T3
(da)
*
|
2008-08-05 |
2015-06-22 |
Toray Industries |
Immunitetsinducerende middel
|
CN102439176B
(zh)
*
|
2009-05-12 |
2018-11-23 |
皇家飞利浦电子股份有限公司 |
用作恶性的、激素-敏感的前列腺癌的标志物的磷酸二酯酶4d7
|
DK2437753T3
(en)
|
2009-06-05 |
2016-12-19 |
Infectious Disease Res Inst |
Synthetic glucopyranosyl lipid adjuvants and vaccine compositions containing them
|
US9938582B2
(en)
|
2009-09-17 |
2018-04-10 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
AU2011211682B2
(en)
|
2010-02-04 |
2015-08-13 |
Toray Industries, Inc. |
Pharmaceutical composition for treating and/or preventing cancer
|
KR101801667B1
(ko)
|
2010-02-04 |
2017-11-27 |
도레이 카부시키가이샤 |
암의 치료 및/또는 예방용 의약 조성물
|
HUE040012T2
(hu)
|
2010-02-04 |
2019-02-28 |
Toray Industries |
Gyógyászati ágens rák kezelésére és/vagy megelõzésére
|
EP2532365B1
(en)
|
2010-02-04 |
2016-05-04 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
AU2011211699B2
(en)
|
2010-02-04 |
2015-01-22 |
Toray Industries, Inc. |
Pharmaceutical composition for treating and/or preventing cancer
|
US8945556B2
(en)
|
2010-11-19 |
2015-02-03 |
The Regents Of The University Of Michigan |
RAF gene fusions
|
AU2012217723A1
(en)
|
2011-02-15 |
2013-08-29 |
Immune Design Corp. |
Methods for enhancing immunogen specific immune responses by vectored vaccines
|
CA2832307A1
(en)
|
2011-04-08 |
2012-10-18 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
DK2740489T3
(en)
|
2011-08-04 |
2017-01-16 |
Toray Industries |
Pharmaceutical composition for the treatment and / or prevention of pancreatic cancer
|
CA2844030C
(en)
|
2011-08-04 |
2019-09-03 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prophylaxis of cancer
|
JP6094220B2
(ja)
|
2011-08-04 |
2017-03-15 |
東レ株式会社 |
膵臓癌の検出方法
|
US9181334B2
(en)
|
2011-08-04 |
2015-11-10 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prophylaxis of cancer
|
AU2012290957B2
(en)
|
2011-08-04 |
2017-04-20 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prophylaxis of cancer
|
MX348578B
(es)
|
2011-08-04 |
2017-06-20 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion de cancer.
|
MX348577B
(es)
|
2011-08-04 |
2017-06-20 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion de cancer.
|
US11510875B2
(en)
|
2012-02-07 |
2022-11-29 |
Access To Advanced Health Institute |
Adjuvant formulations comprising TLR4 agonists and methods of using the same
|
KR102005308B1
(ko)
|
2012-02-21 |
2019-07-30 |
도레이 카부시키가이샤 |
암의 치료 및/또는 예방용 의약 조성물
|
DK2818483T3
(en)
|
2012-02-21 |
2017-10-23 |
Toray Industries |
Medical composition for the treatment and / or prevention of cancer
|
CA2865020C
(en)
|
2012-02-21 |
2021-01-26 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
ES2739612T3
(es)
|
2012-02-21 |
2020-02-03 |
Toray Industries |
Composición farmacéutica para el tratamiento de cáncer
|
MX357965B
(es)
|
2012-03-30 |
2018-08-01 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion de cancer de vesicula biliar.
|
US9416193B2
(en)
|
2012-03-30 |
2016-08-16 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of liver cancer
|
EP2850431B1
(en)
|
2012-05-16 |
2018-04-18 |
Immune Design Corp. |
Vaccines for hsv-2
|
EP3276000A3
(en)
*
|
2012-05-25 |
2018-02-21 |
Cellectis |
Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy
|
CA2879304C
(en)
|
2012-07-19 |
2020-07-14 |
Toray Industries, Inc. |
Method for detecting cancer
|
EP2876447B1
(en)
|
2012-07-19 |
2019-11-20 |
Toray Industries, Inc. |
Method for detecting cancer
|
WO2014041784A1
(en)
|
2012-09-11 |
2014-03-20 |
Oncotherapy Science, Inc. |
Ube2t peptides and vaccines containing the same
|
JP6430949B2
(ja)
|
2012-10-23 |
2018-11-28 |
エモリー ユニバーシティ |
Gm−csfとil−4のコンジュゲート、組成物、ならびにそれに関連する方法
|
CA2909221A1
(en)
|
2013-04-18 |
2014-10-23 |
Immune Design Corp. |
Gla monotherapy for use in cancer treatment
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
DK3031826T3
(en)
|
2013-08-09 |
2018-12-17 |
Toray Industries |
Pharmaceutical composition for the treatment and / or prevention of cancer
|
KR102411781B1
(ko)
|
2013-12-31 |
2022-06-22 |
인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) |
단일 바이알 백신 제형
|
US20170196954A1
(en)
|
2014-07-15 |
2017-07-13 |
Immune Design Corp. |
Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector
|
JOP20200228A1
(ar)
*
|
2015-12-21 |
2017-06-16 |
Novartis Ag |
تركيبات وطرق لخفض تعبير البروتين tau
|
EP3400005A1
(en)
*
|
2016-01-08 |
2018-11-14 |
Vaccibody AS |
Neoepitope rna cancer vaccine
|
WO2017180420A1
(en)
|
2016-04-11 |
2017-10-19 |
Board Of Regents, The University Of Texas System |
Methods and compositions for detecting single t cell receptor affinity and sequence
|
IL299285A
(en)
|
2016-05-16 |
2023-02-01 |
Access To Advanced Health Inst |
Formulation containing a TLR agonist and methods of use
|
IL313085A
(en)
|
2016-05-16 |
2024-07-01 |
Access To Advanced Health Inst |
Pegylated liposomes and methods of use
|
AU2017273650B2
(en)
|
2016-06-01 |
2022-08-18 |
Access To Advanced Health Institute |
Nanoalum particles containing a sizing agent
|
JP7247101B2
(ja)
|
2017-04-03 |
2023-03-28 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
Steap-1に結合する抗体
|
CA3067224A1
(en)
|
2017-06-15 |
2018-12-20 |
Infectious Disease Research Institute |
Nanostructured lipid carriers and stable emulsions and uses thereof
|
CN111315406A
(zh)
|
2017-09-08 |
2020-06-19 |
传染病研究所 |
包括皂苷的脂质体调配物及其使用方法
|
CN113874512A
(zh)
*
|
2018-11-07 |
2021-12-31 |
阿库斯股份有限公司 |
诱导毛细胞分化的组合物和方法
|
CN111000858B
(zh)
*
|
2019-05-10 |
2021-04-09 |
常州市第二人民医院 |
Nupr1抑制剂在制备膀胱癌治疗药物中的用途
|
WO2020243115A1
(en)
|
2019-05-25 |
2020-12-03 |
Infectious Disease Research Institute |
Composition and method for spray drying an adjuvant vaccine emulsion
|
CN111968751B
(zh)
*
|
2020-06-29 |
2021-10-19 |
金电联行(北京)信息技术有限公司 |
一种使用多基线校正模型的传染病趋势预测方法与系统
|
US20230310569A1
(en)
|
2020-09-04 |
2023-10-05 |
Access To Advanced Health Institute |
Genetically-adjuvanted rna vaccines
|
US20230310323A1
(en)
|
2020-09-04 |
2023-10-05 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
EP4048308A1
(en)
|
2020-12-23 |
2022-08-31 |
Infectious Disease Research Institute |
Solanesol vaccine adjuvants and methods of preparing same
|
WO2024052882A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
Immunogenic vaccine composition incorporating a saponin
|